Press release
mRNA Synthesis & Manufacturing Market to Hit USD 738.3 Million by 2029 with 3.4% CAGR | MarketsandMarkets Trademark
The report profiles key players in the mRNA synthesis & manufacturing market such as Thermo Fisher Scientific Inc. (US); Merck KGaA (Germany); Danaher Corporation (US); TriLink BioTechnologies (US)
The global mRNA synthesis and manufacturing market [https://www.marketsandmarkets.com/Market-Reports/mrna-synthesis-manufacturing-market-105705347.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=mrnasynthesisandmanufacturingmarket] is projected to grow from USD 624.4 million in 2024 to USD 738.3 million by 2029, at a CAGR of 3.4%. Key drivers include the growing focus on mRNA-based vaccines, expanding therapeutic applications, advancements in synthesis technology, and industry collaborations. Challenges such as high production costs, stability, and scalability remain hurdles. The rising demand for personalized medicine, particularly in cancer and rare genetic disorder therapies, is accelerating market growth, with major players like BioNTech and Moderna leading innovations. Artificial intelligence is also transforming the sector, optimizing drug development and manufacturing processes. Key opportunities lie in advancements in drug delivery technologies, while North America remains the largest regional market due to significant investments and mRNA's proven efficacy in COVID-19 vaccines.
Download PDF Brochure: [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105705347&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=mrnasynthesisandmanufacturingmarket]
Browse in-depth TOC on "mRNA Synthesis & Manufacturing Market"
250 - Tables
50 - Figures
250 - Pages
The market is expanding rapidly due to factors such as the development of mRNA-based vaccines and expanded applications such as cancer immunotherapies. Furthermore, improvements in mRNA synthesis technology, a rise in mRNA synthesis and modification outsourcing, and industry players working together to create mRNA therapies all contribute to the growth of the mRNA synthesis and manufacturing market. Additionally, factors such as advancements in drug delivery technologies, growth in the regenerative medicines market, and increasing government funding and private investments in the mRNA therapeutics market will further provide revenue growth opportunities for the players operating in mRNA synthesis & manufacturing.
Based on product type, the mRNA synthesis and manufacturing products market is divided into two broad categories, consumables and instruments. The consumables segment of the market held the largest market share in 2023, due to the sustained use of consumables such as nucleotides, RNA polymerase, reverse transcriptase, buffer, and reagents that also require frequent repurchases. The consumables segment will be experiencing high growth due to several factors, including an increase in the mRNA therapeutics pipeline and growing investments made to develop mRNA-based therapeutics, advancement in mRNA synthesis technologies, increase in demand for consumables among contract service providers with the growing trend of outsourcing.
Based on service type, the global mRNA synthesis and manufacturing services market has been categorized into four service types: mRNA synthesis, modification, and related activities; purification of mRNA; analytical and characterization services; and scale-up and manufacture activities. In 2023, the mRNA synthesis and modification services captured the highest market share because of the demand for custom and modified mRNA sequences, which are intended to enhance therapeutic candidates for the molecules market. Given the expanding uses of the mRNA technology, researchers and developers are looking for mRNA sequences that can incorporate protein expression enhancement or immune response improvement.
Based on application, the market for mRNA synthesis and manufacturing has been divided into segments including vaccines and cell & gene therapy. The vaccine segment has the dominant share in the market in 2023. The large share of this segment can be supported by the large number of clinical trials of mRNA vaccines for various diseases infectious diseases, cancer and rare genetic disorders. The remarkable success of mRNA-based COVID-19 vaccines has not only proven the efficacy & scalability of mRNA technology but also catalysed interest in targeting other therapy areas, such as cancer and rare diseases.
Based on end user, the mRNA synthesis and manufacturing market has been categorized into pharmaceutical and biotechnology companies, academic and research institutes, and CROs and CDMOs. In 2023, pharmaceutical and biotechnology companies dominated the market for mRNA synthesis and manufacturing. According to the market's emerging needs, companies are investing to develop next-generation biologics such as mRNA therapeutics. Higher research and development activities of companies to develop mRNA therapeutics and cell and gene therapies have resulted in rising needs for specialized consumables and instruments as well as synthesis, modification, purification, analysis, and characterization services.
Request Sample Pages: [https://www.marketsandmarkets.com/requestsampleNew.asp?id=105705347&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=mrnasynthesisandmanufacturingmarket]
The global mRNA synthesis and manufacturing market is consolidated with the top five players- Thermo Fisher Scientific Inc. (US), Aldevron, LLC. (Danaher Corporation) (US), TriLink BioTechnologies (US), GenScript (US), and Merck KGaA (Germany). Other prominent market players include, New England Biolabs (US), Promega Corporation (US), Sartorius AG (Germany), WuXi Biologics (China), Takara Bio Inc. (Japan), GENEWIZ (Azenta US, Inc.) (US), Lonza (Switzerland), Telesis Bio Inc. (US), Aurigene Pharmaceutical Services Ltd. (Dr. Reddy's Laboratories Ltd.) (India), ST Pharm (South Korea), AGC Biologics (US).
Thermo Fisher Scientific Inc. (US):
Thermo Fisher Scientific Inc., headquartered in Waltham, Massachusetts, is a leading player in mRNA synthesis and manufacturing, offering a broad range of products and services tailored to this field. The company provides advanced solutions for mRNA synthesis, including custom RNA synthesis services and reagents through its GeneArt platform, which supports the development of mRNA constructs for research, therapeutic, and vaccine applications. Thermo Fisher's technologies enable efficient in vitro transcription (IVT) and include automated solutions that enhance scalability and production efficiency. Their extensive expertise, quality assurance measures, and global reach position them as a key player in advancing mRNA technology and supporting the development of next-generation therapeutics and vaccines.
Aldevron, LLC. (Danaher Corporation) (US):
Aldevron, established in 1998 and based in Fargo, North Dakota, is a key player in the nucleic acid synthesis industry, particularly known for its expertise in mRNA synthesis and manufacturing. The company is highly regarded for producing high-quality mRNA and plasmid DNA, essential for cutting-edge applications in vaccine development, gene therapy, and other biotechnological innovations. Aldevron's offerings include custom RNA synthesis and cGMP-compliant mRNA production, ensuring that their products meet the stringent standards required for clinical use. Aldevron's robust quality control and assurance processes further guarantee the reliability and efficacy of their products. As a global leader in the field, Aldevron has expanded its facilities and technological infrastructure to meet growing demand, establishing a significant presence in the biopharmaceutical sector. Their collaborations with biotechnology firms, pharmaceutical companies, and research institutions underscore their pivotal role in advancing mRNA technology and supporting the development of next-generation therapies and vaccines.
TriLink BioTechnologies (US):
TriLink BioTechnologies, a subsidiary of Maravai LifeSciences based in San Diego, California, is a key player in mRNA synthesis and manufacturing. The company excels in providing high-quality nucleic acid products and services, with a strong focus on mRNA technology. TriLink offers comprehensive mRNA synthesis services, including the production of custom mRNA and chemically modified mRNA, which enhances stability and translation efficiency-crucial for effective therapeutic and vaccine development. Utilizing advanced in vitro transcription technologies, TriLink ensures high yield and purity in their mRNA products.
For more information, [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=105705347&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=mrnasynthesisandmanufacturingmarket]
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=mrna-synthesis-manufacturing-market-to-hit-usd-7383-million-by-2029-with-34-cagr-marketsandmarkets]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/hot-melt-adhesives-market-1088.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release mRNA Synthesis & Manufacturing Market to Hit USD 738.3 Million by 2029 with 3.4% CAGR | MarketsandMarkets Trademark here
News-ID: 4016619 • Views: …
More Releases from ABNewswire
Compact Electric Construction Equipment Market to Reach USD 123.69 Billion by 20 …
Mordor Intelligence has published a new report on the Compact Electric Construction Equipment Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Compact Electric Construction Equipment Market Overview
The global compact electric construction equipment market is experiencing rapid growth as construction operators shift from diesel-powered machinery to electric alternatives. Valued at USD 60.37 billion in 2025, the market is projected to reach USD 123.69 billion by 2030, registering a…
Flavor Seed Organic Spice Blends Empower Health-Conscious Families to Enjoy Clea …
Flavor Seed delivers pure organic seasonings that allow families to maintain their commitment to healthy eating throughout the holiday season. The company's USDA Organic, Kosher, and Non-GMO certified blends contain only herbs, spices, and sea salt with zero chemicals or additives. Health-conscious consumers can celebrate without compromising their values or sacrificing flavor.
The holiday season often presents a difficult dilemma for health-conscious consumers who want to participate in festive gatherings without…
New Research Study: New Year's Holiday is the Deadliest Time for Drunk Driving, …
the New Year's holiday period (December 31 to January 1) is now the most dangerous time of the year for alcohol-related crashes, surpassing even the Fourth of July.
As the holiday season reaches its peak, a new analysis commissioned by Avant Law Corporation [https://avantlaw.com/] and conducted by data research firm 1Point21 Interactive [https://www.1point21interactive.com/] highlights a critical danger for motorists. The study reveals that the New Year's holiday period (December 31 to…
From Corporate Geologist to Animal Advocate: The Inspiring Story Behind Crazy K …
Crazy K Farm Pet and Poultry Products emerged from one woman's courageous decision to prioritize family over career when a corporate ultimatum forced an impossible choice. Today, the company holds 19 patents with one pending, plus nine trademarks, and supports over 200 rescued animals through its 501(c)(3) sanctuary. As the year ends and families reflect on what matters most, the founder's journey offers inspiration for the new year ahead.
Behind every…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
